ADC Therapeutics (ADCT) Other Working Capital Changes (2023 - 2026)

ADC Therapeutics has disclosed Other Working Capital Changes across 4 years of filings, most recently posting -$247000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$247000.0, up 93.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 154.7% YoY), and the FY2025 annual result was -$5.2 million, down 453.58% from the prior year.
• Other Working Capital Changes came in at -$247000.0 for Q1 2026 at ADC Therapeutics, down from $215000.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $8.6 million in Q4 2023 to a low of -$9.5 million in Q3 2025.
• The 4-year median for Other Working Capital Changes is -$16000.0 (2025), against an average of $282583.3.
• Across the five-year window, Other Working Capital Changes surged 100.0% in 2024 and plunged 304.28% in 2025, its largest moves.
• ADC Therapeutics' Other Working Capital Changes stood at $8.6 million in 2023, then slumped by 65.52% to $3.0 million in 2024, then sank by 92.78% to $215000.0 in 2025, then sank by 214.88% to -$247000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$247000.0 (Q1 2026), $215000.0 (Q4 2025), and -$9.5 million (Q3 2025), per Business Quant data.